Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03080883Phase 3Completed
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+4 more
PrincipalinvestigatorStart date: 2017-07-14

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Troy Wildes, MD

Washington University School of Medicine

Related
3 trials

Shared therapeutic areas:

Deep Vein ThrombosisPulmonary Embolism
Similarity Score9%

Anshuman Sharma, MD

Washington University School of Medicine

Related
5 trials

Shared therapeutic areas:

Deep Vein ThrombosisPulmonary Embolism
Similarity Score9%

Lorenzo Cohen

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Pulmonary EmbolismDeep Vein Thrombosis
Similarity Score9%

Sumanta K Pal

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Michael Schweizer

Fred Hutch/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Metastatic Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Gil MEYRAND, Dr.

EHPAD "Les Jasses", 155 Rue des Clapas 30730 FONS

Related
1 trials

Shared therapeutic areas:

Deep Vein Thrombosis
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03080883Phase 3PrincipalInvestigator

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+4 more
Completed

All 1 trials loaded